Mucosal antifungal defence: IL-17 signalling takes centre stage

Immunology and Cell Biology

Volumn 89, Issue 8, 2011, Pages 823-825

  Glocker, Erik Oliver ^a   Grimbacher, Bodo ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 3; CRYOPYRIN; DECTIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 6; PROTEIN KINASE SYK; STAT3 PROTEIN;

AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; BONE MARROW CELL; CANDIDA ALBICANS; DENDRITIC CELL; DIABETES MELLITUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KLEBSIELLA PNEUMONIAE; MUCOCUTANEOUS CANDIDIASIS; MYCOSIS; NONHUMAN; NOTE; PHENOTYPE; POINT MUTATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STREPTOCOCCUS PNEUMONIAE; TH17 CELL;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS, CHRONIC MUCOCUTANEOUS; CARD SIGNALING ADAPTOR PROTEINS; DENDRITIC CELLS; HUMANS; IMMUNITY, MUCOSAL; IMMUNOCOMPROMISED HOST; INTERLEUKIN-17; MACROPHAGES; MICE; MUCOUS MEMBRANE; SIGNAL TRANSDUCTION; TH17 CELLS;

EID: 80855132848     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2011.39     Document Type: Note

References (26)

1. Kirkpatrick CH. Chronic mucocutaneous candidiasis. Pediatr Infect Dis J 2001; 20: 197-206. (Pubitemid 32151946)
2. Lilic D. New perspectives on the immunology of chronic mucocutaneous candidiasis. Curr Opin Infect Dis 2002; 15: 143-147. (Pubitemid 34271156)
3. Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech HL et al. Hyper-IgE syndrome with recurrent infections-an autosomal dominant multisystem disorder. N Engl J Med 1999; 340: 692-702. (Pubitemid 29110753)
4. Ahonen P, Myllärniemi S, Sipilä I, Perheentupa J. Clinical variation of autoimmune polyendocrino-pathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 1990; 322: 1829-1836. (Pubitemid 20200407)
5. Puel A, Cypowyj S, Bustamante J, Wright JF, Liu L, Lim HK et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 2011; 332: 65-68.
6. Ruland J. CARD9 signaling in the innate immune response. Ann NY Acad Sci 2008; 1143: 35-44.
7. Poeck H, Ruland J. ITAM receptor signaling and the NLRP3 inflammasome in antifungal immunity. J Clin Immunol 2010; 30: 496-501.
8. Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 2009; 206: 299-311.
9. Onishi RM, Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 2010; 129: 311-321.
10. Peric M, Koglin S, Kim SM, Morizane S, Besch R, Prinz JC et al. IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes. J Immunol 2008; 181: 8504-8512.
11. Liang S, Tan X, Luxenberg D, Karim R, Dunussi-Joannopoulos K, Collins M et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 2006; 203: 2271-2279. (Pubitemid 44498362)
12. Eyerich K, Foerster S, Rombold S, Seidl HP, Behrendt H, Hofmann H et al. Patients with chronic mucocuta-neous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22. J Invest Derma-tol 2008; 128: 2640-2645.
13. Glocker EO, Hennigs A, Nabavi M, Schäffer AA, Woell-ner C, Salzer U et al. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med 2009; 361: 1727-1735.
14. Ma CS, Chew GY, Simpson N, Priyadarshi A, Wong M, Grimbacher B et al. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med 2008; 205: 1551-1557. (Pubitemid 351962018)
15. Milner JD, Brenchley JM, Laurence A, Freeman AF, Hill BJ, Elias KM et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008; 452: 773-776. (Pubitemid 351521078)
16. de Beaucoudrey L, Puel A, Filipe-Santos O, Cobat A, Ghandil P, Chrabieh M et al. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med 2008; 205: 1543-1550. (Pubitemid 351962017)
17. Minegishi Y, Saito M, Nagasawa M, Takada H, Hara T, Tsuchiya S et al. Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome. J Exp Med 2009; 206: 1291-1301.
18. Stockinger B, Veldhoen M. Differentiation and function of Th17T cells. Curr Opin Immunol 2007; 19: 281-286.
19. Ochs HD, Oukka M, Torgerson TR. Th17 cells and regulatory T cells in primary immunodeficiency diseases. J Allergy Clin Immunol 2009; 123: 977-983.
20. Kisand K, Bøe Wolff AS, Podkrajsek KT, Tserel L, Link M, Kisand KV et al. Chronic mucocutaneous candidia-sis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med 2010; 207: 299-308.
21. Puel A, Döffinger R, Natividad A, Chrabieh M, Barcenas-Morales G, Picard C et al. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med 2010; 207: 291-297.
22. Zhang Z, Clarke TB, Weiser JN. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest 2009; 119: 1899-1909.
23. Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 2001; 194: 519-527. (Pubitemid 32835046)
24. Ishigame H, Kakuta S, Nagai T, Kadoki M, Nambu A, Komiyama Y et al. Differential roles of interleukin-17A and-17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 2009; 30: 108-119.
25. Schwarzenberger P, Huang W, Ye P, Oliver P, Manuel M, Zhang Z et al. Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis. J Immunol 2000a; 164: 4783-4789. (Pubitemid 30238080)
26. Cho JS, Pietras EM, Garcia NC, Ramos RI, Farzam DM, Monroe HR et al. IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J Clin Invest 2010; 120: 1762-1773.